Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-12

Clinical Trial Update: Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis

View source ↗

Summary

This clinical trial update reports that gammaglobulin levels may serve as a predictor of disease evolution in sarcoidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rennes University Hospital | Conditions: Sarcoidosis | Status: COMPLETED